Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 8874508)

Published in Virology on October 15, 1996

Authors

N D Christensen1, C A Reed, N M Cladel, K Hall, G S Leiserowitz

Author Affiliations

1: Department of Pathology, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA. ndc1@email.psu.edu

Articles citing this

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin Diagn Lab Immunol (2003) 3.76

Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol (2005) 2.72

Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol (2007) 2.05

Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines. J Natl Cancer Inst (2009) 1.95

Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2. J Virol (2007) 1.70

Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol (2006) 1.67

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J Virol (2002) 1.35

In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J Virol (1998) 1.20

Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles. Virology (2007) 1.07

Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Virol J (2012) 1.04

Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cell Microbiol (2013) 1.00

Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers. J Virol (2005) 0.98

Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33. Virol J (2006) 0.95

Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant. J Immune Based Ther Vaccines (2005) 0.95

Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies. J Gen Virol (2009) 0.87

Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses. J Virol (2009) 0.87

Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications. Protein Sci (2009) 0.86

Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types. Hum Vaccin Immunother (2014) 0.86

Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope. BMC Microbiol (2004) 0.85

Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation. PLoS One (2013) 0.84

Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum. BMC Biotechnol (2007) 0.81

Cross-neutralizing antibodies elicited by the Cervarix® human papillomavirus vaccine display a range of Alpha-9 inter-type specificities. Vaccine (2014) 0.81

Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine. Clin Vaccine Immunol (2012) 0.80

Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins. Hum Vaccin Immunother (2015) 0.79

Influence of oxidation and multimerization on the immunogenicity of a thioredoxin-l2 prophylactic papillomavirus vaccine. Clin Vaccine Immunol (2013) 0.79

Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus. Virus Res (2011) 0.76

Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58. Sci Rep (2016) 0.75

Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs. Eur J Microbiol Immunol (Bp) (2014) 0.75

Articles by these authors

Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry (2001) 4.04

Effects of castration and of sexual hormones on the adrenals of male rats. J Physiol (1938) 3.95

The effects of testosterone and testosterone propionate on adult male rats (compared with those on female rats). Biochem J (1937) 3.42

Novel heterotrimeric kinesin-related protein purified from sea urchin eggs. Nature (1993) 3.22

"Picket fence porphyrins." Synthetic models for oxygen binding hemoproteins. J Am Chem Soc (1975) 2.86

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology (1996) 2.83

The action of testosterone propionate on normal adult female rats. Biochem J (1937) 2.80

Somatomedin: proposed designation for sulphation factor. Nature (1972) 2.63

Correlation between sex hormones, thyroid hormones and desoxycorticosterone as judged by their effects on the weights of organs of gonadectomized rats. Biochem J (1941) 2.61

"Spontaneous" transfer of stimulus control from tact to mand contingencies. Res Dev Disabil (1990) 2.59

Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J Virol (1990) 2.26

Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab (1994) 2.21

A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature (1990) 2.20

Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. Oncogene (2010) 2.14

A major outbreak of foodborne gastroenteritis among Air Force personnel during Operation Desert Storm. Mil Med (1993) 2.10

Employing people with disabilities. J Long Term Care Adm (1994) 2.03

The manifold effects of prolonged administration of sex hormones to female rats. Biochem J (1939) 1.95

The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J Am Geriatr Soc (2000) 1.87

Structure of an iron(II) dioxygen complex; a model for oxygen carrying hemeproteins. Proc Natl Acad Sci U S A (1974) 1.85

Syntheses of ferrous-porphyrin complexes. A hypothetical model for deoxymyoglobin. J Am Chem Soc (1973) 1.84

Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene (1998) 1.81

Insulin-like growth factors and their binding proteins. Physiol Rev (1990) 1.79

Prolonged administration of sex hormones to castrated rats. Biochem J (1939) 1.76

Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med (1987) 1.74

Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol (1994) 1.67

Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J Virol (1996) 1.66

Effects of bromocriptine on pituitary tumour size. Br Med J (1979) 1.64

Dissociative disorders in psychiatric inpatients. Am J Psychiatry (1993) 1.59

Synthesis, stereochemistry, and structure-related properties of alpha, beta, gamma, delta-tetraphenylporphinatoiron(II). J Am Chem Soc (1975) 1.55

Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Virology (2001) 1.52

Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab (1995) 1.51

Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) (1991) 1.50

'Z-RNA'--a left-handed RNA double helix. Nature (1984) 1.48

Conserved features in papillomavirus and polyomavirus capsids. J Mol Biol (1996) 1.47

Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology (2010) 1.46

Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab (1994) 1.44

Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins. South Med J (2001) 1.43

Allergy of the nervous system: a review. Ann Allergy (1976) 1.41

Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies. Virology (1995) 1.40

Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate. Antimicrob Agents Chemother (2001) 1.39

Critical care research ethics: making the case for non-consensual research in ICU. Crit Care Resusc (2004) 1.39

Anatomical and Histological Studies of an Intersexual Lesser Shrew (Sorex minutus L.), with Special Reference to the Effects of the Male Hormones on the Uterus and Vagina. J Anat (1936) 1.38

A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses. Antimicrob Agents Chemother (1999) 1.35

Search for neutrinoless double-beta decay in 136Xe with EXO-200. Phys Rev Lett (2012) 1.33

Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol (2001) 1.33

Light and electron microscopic studies of the guinea pig cytomegalovirus. J Ultrastruct Res (1967) 1.33

Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7. J Clin Pathol (2009) 1.31

Glasgow Outcome Scale and Disability Rating Scale: comparative usefulness in following recovery in traumatic head injury. Arch Phys Med Rehabil (1985) 1.29

Lipids in the mouse uterus during early pregnancy. J Endocrinol (1975) 1.29

The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type II to disinfection with povidone-iodine. Am J Ophthalmol (1990) 1.29

High magnetic field Mössbauer studies of deoxymyoglobin, deoxyhemoglobin, and synthetic analogues. Biochim Biophys Acta (1979) 1.28

Possible medication errors in home healthcare patients. J Am Geriatr Soc (2001) 1.27

Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) (1984) 1.25

Plasma pattern of immunoreactive ACTH in normal man and in patients with Nelson's syndrome. Acta Endocrinol (Copenh) (1981) 1.25

Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins. Virology (1990) 1.23

Head injury rehabilitation: benefit of early intervention. Arch Phys Med Rehabil (1982) 1.23

The normal course of separation of the pubes in pregnant mice. J Physiol (1946) 1.22

Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid. Eur J Biochem (1984) 1.20

Reduplication of nuclear membranes in tissue-culture cells infected with guinea-pig cytomegalovirus. Am J Pathol (1967) 1.19

Further purification and characterization of sulfation factor and thymidine factor from acromegalic plasma. J Clin Endocrinol Metab (1971) 1.18

Evidence for Z-form RNA by vacuum UV circular dichroism. Nucleic Acids Res (1985) 1.18

The action of the dipropionate and benzoate-butyrate of oestradiol on ovariectomized rats. Biochem J (1939) 1.18

Ontogenesis of somatomedin and insulin receptors in the human fetus. J Clin Invest (1983) 1.17

Early stroke recognition: developing an out-of-hospital NIH Stroke Scale. Acad Emerg Med (1997) 1.17

Primary hyperparathyroidism in children. Brief review of the literature and a case report. Acta Paediatr Scand (1970) 1.15

A (carbonmonoxy)heme complex with a weak proximal bond. Molecular stereochemistry of carbonyl(deuteroporphinato)(tetrahydrofuran)iron(II). Biochemistry (1981) 1.15

Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. J Invest Dermatol (1995) 1.14

Far upstream regulatory elements enhance position-independent and uterus-specific expression of the murine alpha1(I) collagen promoter in transgenic mice. Gene Expr (1999) 1.14

Immunoreactive somatomedin A in human serum. J Clin Endocrinol Metab (1979) 1.13

Letter: Reversible oxygen adduct formation in ferrous complexes derived from a "picket fence" prophyrin. A model for oxymyoglobin. J Am Chem Soc (1973) 1.13

Radioreceptor assay for somatomedin A. J Clin Endocrinol Metab (1974) 1.12

Purified human somatomedin A and rat multiplication stimulating activity. Mitogens for cultured fibroblasts that cross-react with the same growth peptide receptors. Eur J Biochem (1978) 1.10

Evaluation of a latex agglutination test for herpes simplex virus. J Clin Microbiol (1988) 1.10

Isolation and characterization of polycyclic aromatic hydrocarbon-degrading Mycobacterium isolates from soil. Microb Ecol (2004) 1.09

Extensive synthesis of poly[r(G-C)] using Escherichia coli RNA polymerase. Arch Biochem Biophys (1985) 1.08

Reduction in size of a pituitary tumor by bromocriptine therapy. N Engl J Med (1979) 1.08

Erythromycin-related dystonic reaction. Am J Emerg Med (1992) 1.08

Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer (2006) 1.08

Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. BMJ (1988) 1.08

A theory for the membrane potential of living cells. Eur Biophys J (2000) 1.07

Experimental infection with human papillomavirus type 1 of human hand and foot skin. Virology (1990) 1.07

Liver Changes in Male Rats after Castration and Injection of Sex Hormones. Br Med J (1938) 1.06

Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes. J Virol (1999) 1.06

Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients. Cancer Res (1992) 1.05

What inner ear diseases cause benign paroxysmal positional vertigo? Acta Otolaryngol (2000) 1.04

Growth and somatomedins. Vitam Horm (1983) 1.04

Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts. J Infect Dis (1991) 1.04

Evoked brain potentials and disability in brain-damaged patients. Arch Phys Med Rehabil (1977) 1.04

High efficiency induction of papillomas in vivo using recombinant cottontail rabbit papillomavirus DNA. J Virol Methods (1995) 1.04

A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann N Y Acad Sci (1993) 1.03

Quantative determination of the sulphation factor activity in human serum. Acta Endocrinol (Copenh) (1970) 1.03

Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab (1995) 1.03

DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits. J Virol (2000) 1.02